B
BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ · Healthcare · 726M
Closing price
$3.31
-3.22% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.3×
Enterprise value / EBITDAEV/EBITDA
1.8×
Free cash flow yieldFCF yield
-111.1%
Return on equityROE
-32.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.